Effect of adjunctive prophylactic macrolides used at the caesarean section on endometritis and surgical site wound infection: A meta-analysis

Int Wound J. 2023 Oct;20(8):3307-3314. doi: 10.1111/iwj.14211. Epub 2023 May 9.

Abstract

A meta-analysis investigation was executed to measure the outcome of adjunctive prophylactic macrolides (APM) used at caesarean section (CS) on endometritis and surgical site wound infection (SSWI). A comprehensive literature inspection till February 2023 was applied and 1023 interrelated investigations were reviewed. The 10 chosen investigations enclosed 22 676 females with CS were in the chosen investigations' starting point, 14 034 of them were utilising APM, and 8642 were utilising control. Odds ratio (OR) in addition to 95% confidence intervals (CIs) were used to compute the value of the effect of APM used at CS on endometritis and SSWI by the dichotomous approaches and a fixed or random model. Adjunctive prophylactic macrolides had significantly lower SSWI (OR, 0.43; 95% CI, 0.34-0.55, P < .001), and endometritis (OR, 0.34; 95% CI, 0.20-0.60, P = .005) compared with those with control in females with CS. Adjunctive prophylactic macrolides had significantly lower SSWI, and endometritis compared with those with control in females with CS. However, care must be exercised when dealing with its values because of the low number of nominated investigations for the meta-analysis.

Keywords: amputation; endovascular; limb salvage; peripheral artery diseases.

Publication types

  • Meta-Analysis

MeSH terms

  • Anti-Bacterial Agents / therapeutic use
  • Cesarean Section* / adverse effects
  • Endometritis* / drug therapy
  • Endometritis* / prevention & control
  • Female
  • Humans
  • Macrolides / therapeutic use
  • Pregnancy
  • Surgical Wound Infection / drug therapy
  • Surgical Wound Infection / prevention & control

Substances

  • Macrolides
  • Anti-Bacterial Agents